Mesenchymal stem cells biological properties and possibilities of clinical use

QR Code

Mesenchymal stem cells biological properties and possibilities of clinical use

Autologic and allogeneic mesenchymal stem cells (MSC) transplantation currently is used in clinical practice for hematopoietic progenitor engraftment acceleration and graft versus host disease prophylactic and treatment. In this literature review data concerning efficacy, safety and technologies of...

Full description

Saved in:

Bibliographic Details
Main Authors:	O. S. Tatarinova, E. Yu. Osipova, S. A. Roumiantsev
Format:	Article
Language:	Russian
Published:	ABV-press 2022-11-01
Series:	Онкогематология
Subjects:	mesenchymal stem cells (msc) hematopoietic stem cells transplantation msc transplantation graft versus host disease long-term culture
Online Access:	https://oncohematology.abvpress.ru/ongm/article/view/784
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Role of the regulatory T cells CD4+CD25+ and mesenchymal marrow stem cells in suppressing a graft versus host reaction
by: I. A. Korsunsky, et al.
Published: (2022-11-01)

Regulatory T-cells and allogeneic hematopoietic stem cell transplantation
by: O. S. Karavaeva, et al.
Published: (2022-12-01)

The late outcomes of syngeneic hematopoietic stem cell transplantation in patients with blood disorders
by: A. A. Dmitrova, et al.
Published: (2022-11-01)

Efficacy and safety of ruxolitinib combined with steroids for first-line treatment of acute graft-versus-host disease after hematopoietic stem cell transplantation: a single-center, real-world experience
by: Yan Yang, et al.
Published: (2025-07-01)

CLINICAL EFFECTS OF MESENCHYMAL STROMAL CELLS IN LYMPHOMA PATIENTS WITH AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION
by: E. V. Batorov, et al.
Published: (2012-05-01)

Anti-monocyte globulin in allogeneic transplantation of hematopoietic stem cells
by: Yu. R. Zalyalov, et al.
Published: (2022-11-01)

Restoration of limited defects of the cartilage with the use of cell-engineered constructs
by: S. A. Gerasimov, et al.
Published: (2018-01-01)

Clinical Features of Cutaneous Acute Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cells Transplantation in Children with Hemato-Oncological Diseases
by: Tatiana S. Belysheva, et al.
Published: (2020-12-01)

Decreased frequency and inflammatory change of FoxP3+ regulatory T cells in immunopathogenesis of human acute graft-versus-host disease
by: Nayeon Seong, et al.
Published: (2025-07-01)

PHARMACOECONOMIC ANALYSIS OF DIFFERENT METHODS FOR THE TREATMENT OF STEROID-REFRACTORY GRAFT-VERUS-HOST DISEASE: SINGLE-CENTER STUDY
by: I. S. Moiseev, et al.
Published: (2018-03-01)

Impact of Decitabine Conditioning on Allo‐HSCT Outcomes in AML and Intermediate‐to‐High‐Risk MDS Patients in Remission
by: Shuling Yu, et al.
Published: (2025-07-01)

A higher ratio of IL-2/IL-4 may be an early predictor of acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation
by: Yu Fu, et al.
Published: (2025-07-01)

Extracorporeal photopheresis in the treatment of graft-versus-host disease
by: I. V. Guz, et al.
Published: (2016-03-01)

Current Trends in the Use of Cell Therapy in Regenerative Medicine
by: A. A. Chaplenko, et al.
Published: (2020-06-01)

Basic Molecular Biology, Metabolic and Immunological Mechanisms of Fecal Microbiota Transplantation
by: O. V. Goloshchapov, et al.
Published: (2024-12-01)

Potential of Using New Indole- and Benzimidazo[1,2-C]quinazolines in Anticancer Therapy Based on Mesenchymal Stem Cells
by: Radzikowska-Bűchner E, et al.
Published: (2025-06-01)

Application experience of extracorporeal photopheresis for treatment of acute “graft-versus-host” disease after allogeneic hematopoietic stem cell transplantation
by: A. V. Kozlov, et al.
Published: (2014-07-01)

LYMPHOID NEOPLASMS AFTER ALLOGENEIC HEMATOPOIETIC STEM CELLS TRANSPLANTATION. THE CASE OF SECONDARY HODGKIN’S LYMPHOMA, DIFFERENTIAL DIAGNOSIS WITH POST-TRANSPLANT LYMPHOPROLIFERATIVE DISEASE
by: Yu. V. Skvortsova, et al.
Published: (2017-06-01)

Advanced Therapeutic Approaches Based on Small Extracellular Vehicles (sEVs) For the Regeneration of Spinal Cord Injuries
by: Anjum A, et al.
Published: (2025-06-01)

In vitro and In vivo Studies on Mesenchymal Stem Cells for Ischemic Stroke Therapy: A Scoping Review of The Therapeutic Effect
by: Rinendyaputri R, et al.
Published: (2025-05-01)

Treatment of Radiation Lesions with Mesenchymal Stem Cells
by: Já. Lakota
Published: (2023-08-01)

Donor‐derived M2 macrophages attenuate GVHD after allogeneic hematopoietic stem cell transplantation
by: Ryo Hanaki, et al.
Published: (2021-12-01)

Case Report: Successful treatment of steroid- and ruxolitinib-refractory gastrointestinal acute graft-versus-Host disease with anti-thymocyte globulin
by: Lulu Zhang, et al.
Published: (2025-07-01)

Autologous hematopoietic stem cell transplantation in the treatment of systemic sclerosis. Part 1. Clinical aspects
by: O. B. Ovsyannikova, et al.
Published: (2020-11-01)

Factors associated with the number of CD34-positive hematopoietic progenitor cells in the leukocyte concentrate in patients with lymphomas and acute T-lymphoblastic leukemia
by: I. V. Galtseva, et al.
Published: (2024-12-01)

Features of transfusion therapy in hematopoietic stem cell transplantation
by: M. A. Kucher, et al.
Published: (2016-12-01)

Cell therapy in pediatric blood diseases
by: Rubí Romo-Rodríguez, et al.
Published: (2025-06-01)

EVALUATION OF QUALITATIVE AND QUANTITATIVE INDICATORS OF SUBSTITUTIONARY TRANSFUSION THERAPY IN DIFFERENT TYPES OF HEMATOPOIETIC STEM CELL TRANSPLANTATION
by: M. A. Kucher, et al.
Published: (2017-03-01)

Comparing drug combinations for graft-versus-host disease prophylaxis using the U.S. Food and Drug Administration Adverse Event Reporting System
by: Toru Ogura, et al.
Published: (2025-06-01)

Effect of <i>CTLA4</i> gene polymorphism on relapse probability among patients with acute leukemias after allogenic hematopoietic stem cells transplantation
by: D. S. Romaniuk, et al.
Published: (2019-04-01)

Late non-infectious lung damage in children after allogeneic hematopoietic stem cells transplantation
by: Yu. V. Skvortsova, et al.
Published: (2015-06-01)

DONOR CHIMERISM IN PATIENTS WITH PRIMARY IMMUNODEFICIENCY AFTER ALLOGENEIC HEMATOPOIETIC STEM CELLS TRANSPLANTATION
by: V. A. Lavrinenko, et al.
Published: (2018-07-01)

Monitoring of chimerism after allogeneic hematopoietic stem cell transplantation
by: D. S. Dubnyak, et al.
Published: (2022-12-01)

Study of the Role of Heparin in Regulation of the Morphofunctional Properties of MSC <i>in Vitro</i>
by: I. K. Norkin, et al.
Published: (2022-05-01)

Evaluation Transplantation of Bone-Derived Mesenchymal Stem Cell in the Patients with Hepatitis C-Related Liver Cirrhosis (Pi lot Study)
by: S. P. Lukashyk, et al.
Published: (2021-03-01)

Preventing the rejection of skin allografts by immunomodulatory and regenerative effects of exosomes derived from bone marrow mesenchymal stem cells in mice
by: Parham Soufizadeh, et al.
Published: (2025-04-01)

Cryostorage of peripheral blood hematopoietic stem cells in transplantology: current status and prospects
by: O. I. Kit, et al.
Published: (2023-12-01)

Therapy efficacy in multiple myeloma patients received autologous stem cells transplantation as first line therapy
by: Ye. I. Darskaya, et al.
Published: (2014-07-01)

CLINICAL EFFECTIVENESS OF HIGH-DOSE IMMUNOSUPPRESSIVE THERAPY WITH AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION IN MULTIPLE SCLEROSIS PATIENTS
by: D. A. Fedorenko, et al.
Published: (2014-12-01)

Results of allogeneic hematopoietic stem cell transplantation in a patient with classical Hodgkin's lymphoma
by: A. Р. Strelnikova, et al.
Published: (2021-05-01)